Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer

Oncotarget

Volumn 2, Issue 12, 2011, Pages 1291-1301

  Piazzi, Giulia ^a,b,c   Fini, Lucia ^c,d   Selgrad, Michael ^c,e   Garcia, Melissa ^c   Daoud, Yahya ^f   Wex, Thomas ^e   Malfertheiner, Peter ^e   Gasbarrini, Antonio ^g   Romano, Marco ^h   Meyer, Richard L ^f   Genta, Robert M ⁱ   Fox, James G ^j   Boland, C Richard ^c   Bazzoli, Franco ^a   Ricciardiello, Luigi ^a,b,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c BAYLOR RESEARCH INSTITUTE   (United States)

^d Otto von Guericke University Magdeburg ^*  (Italy)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g CATHOLIC UNIVERSITY   (Italy)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j Massachusetts Institute of Technology Cambridge   (United States)

more..

Author keywords

Delta like 1; Gastric cancer; Methylation; Notch

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ATOH1 PROTEIN, MOUSE; AZACITIDINE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CALCIUM BINDING PROTEIN; DLK1 PROTEIN, MOUSE; DRUG DERIVATIVE; HES1 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; MEMBRANE PROTEIN; NOTCH1 PROTEIN, MOUSE; NOTCH1 RECEPTOR; SERRATE PROTEINS; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; METABOLISM; MOUSE; PATHOGENICITY; PATHOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; AZACITIDINE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; PROMOTER REGIONS, GENETIC; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84862981221     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.414     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.
2. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell. 2004; 5:121-125.
3. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer. 2002; 100:249-260.
4. Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004; 131:965-973.
5. D'Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene. 2008; 27:5148-5167.
6. Katoh M. Notch signaling in gastrointestinal tract (review). Int J Oncol. 2007; 30:247-251.
7. Miele L. Notch signaling. Clin Cancer Res. 2006; 12:1074- 1079.
8. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F, Clevers H. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005; 435:959-963.
9. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003; 194:237-255.
10. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD. Control of endodermal endocrine development by Hes-1. Nat Genet. 2000; 24:36-44.
11. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 2001; 294:2155-2158.
12. Sekine A, Akiyama Y, Yanagihara K, Yuasa Y. Hath1 up-regulates gastric mucin gene expression in gastric cells. Biochem Biophys Res Commun. 2006; 344:1166-1171.
13. Kim TH, Shivdasani RA. Notch signaling in stomach epithelial stem cell homeostasis. J Exp Med. 2011; 208:677- 688.
14. Crosnier C, Vargesson N, Gschmeissner S, Ariza-McNaughton L, Morrison A, Lewis J. Delta-Notch signaling controls commitment to a secretory fate in the zebrafish intestine. Development. 2005; 132:1093-1104.
15. Pellegrinet L, Rodilla V, Liu Z, Chen S, Koch U, Espinosa L, Kaestner KH, Kopan R, Lewis J, Radtke F. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology. 2011; 140:1230- 1240 e1231-1237.
16. Matsuda Y, Wakamatsu Y, Kohyama J, Okano H, Fukuda K, Yasugi S. Notch signaling functions as a binary switch for the determination of glandular and luminal fates of endodermal epithelium during chicken stomach development. Development. 2005; 132:2783-2793.
17. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H. Notch signaling controls pancreatic cell differentiation. Nature. 1999; 400:877-881.
18. Scoville DH, Sato T, He XC, Li L. Current view: intestinal stem cells and signaling. Gastroenterology. 2008; 134:849- 864.
19. Lee CW, Rickman B, Rogers AB, Ge Z, Wang TC, Fox JG. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2008; 68:3540-3548.
20. Poellinger L, Lendahl U. Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms. Curr Opin Genet Dev. 2008; 18:449-454.
21. Ball DW, Leach SD. Notch in malignancy. Cancer Treat Res. 2003; 115:95-121.
22. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer. 2003; 3:756-767.
23. Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC, Li AF, Wang AM, Kuo ML, Chi CW. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res. 2009; 69:5039- 5048.
24. Lauren P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand. 1965; 64:31-49.
25. Hamilton JP, Meltzer SJ. A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol. 2006; 4:416- 425.
26. Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett. 2008; 266:99- 115.
27. Gutierrez-Gonzalez L, Wright NA. Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration. Dig Liver Dis. 2008; 40:510-522.
28. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007; 133:659-672.
29. Kang GH, Lee S, Cho NY, Gandamihardja T, Long TI, Weisenberger DJ, Campan M, Laird PW. DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest. 2008; 88:161-170.
30. Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. PGP9.5 methylation in diffuse-type gastric cancer. Cancer Res. 2006; 66:3921- 3927.
31. Zhang X, Yu H, Yang Y, Zhu R, Bai J, Peng Z, He Y, Chen L, Chen W, Fang D, Bian X, Wang R. SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathological features and prognosis. J Gastrointest Surg. 2010; 14:1220-1226.
32. Park ET, Oh HK, Gum JR, Jr., Crawley SC, Kakar S, Engel J, Leow CC, Gao WQ, Kim YS. HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin Cancer Res. 2006; 12:5403-5410.
33. Talora C, Campese AF, Bellavia D, Felli MP, Vacca A, Gulino A, Screpanti I. Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes. Biochim Biophys Acta. 2008; 1782:489-497.
34. Yanai K, Nakamura M, Akiyoshi T, Nagai S, Wada J, Koga K, Noshiro H, Nagai E, Tsuneyoshi M, Tanaka M, Katano M. Crosstalk of hedgehog and Wnt pathways in gastric cancer. Cancer Lett. 2008; 263:145-156.
35. Aragaki M, Tsuchiya K, Okamoto R, Yoshioka S, Nakamura T, Sakamoto N, Kanai T, Watanabe M. Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer. Biochem Biophys Res Commun. 2008; 368:923-929.
36. Tsuchiya K, Nakamura T, Okamoto R, Kanai T, Watanabe M. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer. Gastroenterology. 2007; 132:208-220.
37. Ingram WJ, McCue KI, Tran TH, Hallahan AR, Wainwright BJ. Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signaling. Oncogene. 2008; 27:1489-1500.
38. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, Wang TC. Helicobacter pylori associated gastric cancer in INS-GAS mice is gender-specific. Cancer Res. 2003; 63:942-950.
39. Sun Y, Gao X, Liu J, Kong QY, Wang XW, Chen XY, Wang Q, Cheng YF, Qu XX, Li H. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers. Arch Pathol Lab Med. 2011; 135:451-458.
40. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol. 2009; 472:467-477.
41. Grosveld GC. Gamma-secretase inhibitors: Notch so bad. Nat Med. 2009; 15:20-21.
42. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene. 2008; 27:5124-5131.
43. Shih Ie M, Wang TL. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res. 2007; 67:1879- 1882.